NRG1 and peritoneal carcinoma: Of the 14,395 samples obtained from ovarian, fallopian tube, or primary peritoneal carcinomas that were tested by whole transcriptome sequencing, 26 were shown to harbor NRG1 fusions (incidence of 0.18%) between 2019 and 2023.